Clinical Trial Update: Mucopolysaccharidosis I (MPS I) Registry

View source ↗

Summary

This entry reports the completion of the Mucopolysaccharidosis I registry clinical trial sponsored by Genzyme. No specific results are provided in this entry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Mucopolysaccharidosis I (MPS I) | Status: COMPLETED